NeoMatriX Wound Matrix— 510(k) K181330
Substantially EquivalentNextgen Biologics, Inc.
FDA 510(k) clearance K181330 for NeoMatriX Wound Matrix, Substantially Equivalent on 2018-10-11. Applicant: Nextgen Biologics, Inc..
Clearance details
- Applicant
- Nextgen Biologics, Inc.
- Product code
- Code KGN
- Advisory panel
- Unknown
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Gainesville, FL, US
Adverse events under product code KGN
product code KGN- Other
- 2
- Total
- 2
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Data sourced from openFDA. This site is unofficial and independent of the FDA.